ADME Design / Troubleshooting
With over 20 years as a Senior Radiation Protection Supervisor (SRPS) within the pharmaceutical industry, and for the most part being responsible for clinical study supply, labelling and formulation development Paul Cummings is well placed to critique plans for your Administration Distribution Metabolism and Excretion (ADME)studies.
Paul can advise on troublesome formulations, especially those involving high radioactivity and low solubility. Manufacturing options, risk analysis and small volume parenteral use of IV/Oral dosing cross over studies.
He can critique regulatory submissions and provide expert analysis reports on study plans or stability data interpretation.
Please call us to discuss your requirements.